{"DataElement":{"publicId":"3109755","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Laboratory Procedure Outcome Type","preferredDefinition":"a subdivision related to clinical trials cooperative group supported by the NCI with group headquarters in Pittsburgh, Pennsylvania and research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia list of procedures that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"3109749v1.0:3109750v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3109749","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Laboratory Procedure Outcome","preferredDefinition":"information related to clinical trials cooperative group supported by the NCI with group headquarters in Pittsburgh, Pennsylvania and research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia list of procedures that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"3109747v1.0:2224045v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3109747","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project Laboratory Procedure","preferredDefinition":"The National Surgical adjuvant Breast and Bowel Project (NSABP) is a clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. . In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C15818:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Surgical Adjuvant Breast and Bowel Project","conceptCode":"C15818","definition":"A clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CEE7-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224045","version":"1","preferredName":"Outcome","preferredDefinition":"A phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F061C-D115-4EFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CEF5-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3109750","version":"1","preferredName":"NSABP Laboratory Procedure Outcome Type","preferredDefinition":"a subdivision of laboratory procedure for NSABP.","longName":"3109750v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Calculated Creatinine Clearance","valueDescription":"Calculated creatinine clearance","ValueMeaning":{"publicId":"2573762","version":"1","preferredName":"Calculated creatinine clearance","longName":"2573762","preferredDefinition":"Calculated creatinine clearance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED2F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-23","modifiedBy":"CAMPBELB","dateModified":"2005-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF27-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"CEA","valueDescription":"CEA","ValueMeaning":{"publicId":"2561900","version":"1","preferredName":"CEA","longName":"2561900","preferredDefinition":"CEA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BED9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-22","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF32-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"24-Hour Urine Collection","valueDescription":"24-Hour Urine Collection","ValueMeaning":{"publicId":"3109751","version":"1","preferredName":"24-Hour Urine Collection","longName":"3109751","preferredDefinition":"24-Hour Urine Collection","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CF3D-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF56-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Urine Dipstick","valueDescription":"Urine Dipstick","ValueMeaning":{"publicId":"3109752","version":"1","preferredName":"Urine Dipstick","longName":"3109752","preferredDefinition":"Urine Dipstick","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CF60-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF79-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Hemoglobin","valueDescription":"HEMOGLOBIN","ValueMeaning":{"publicId":"2561802","version":"1","preferredName":"HEMOGLOBIN","longName":"2561802","preferredDefinition":"HEMOGLOBIN","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin","conceptCode":"C16676","definition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE77-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-09","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF83-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Platelet Count","valueDescription":"Platelet Count","ValueMeaning":{"publicId":"2833094","version":"1","preferredName":"Platelet Count","longName":"2833094","preferredDefinition":"The determination of the number of platelets in a blood sample, usually expressed as platelets per cubic millimeter (cmm) of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Count","conceptCode":"C51951","definition":"The determination of the number of platelets in a biospecimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621D07D9-0207-271C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-04","modifiedBy":"COLBERTM","dateModified":"2022-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF8E-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"ANC","valueDescription":"ANC","ValueMeaning":{"publicId":"2561877","version":"1","preferredName":"ANC","longName":"2561877","preferredDefinition":"ANC","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BEC2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-22","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CF99-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Serum Creatinine","valueDescription":"Serum Creatinine","ValueMeaning":{"publicId":"2965228","version":"1","preferredName":"Serum Creatinine","longName":"2965228","preferredDefinition":"The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.: The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A3CBEBF-AF99-A0A7-E040-BB89AD435054","latestVersionIndicator":"Yes","beginDate":"2009-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-08","modifiedBy":"KUMMEROA","dateModified":"2023-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CFAE-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Total Bilirubin","valueDescription":"Total Bilirubin","ValueMeaning":{"publicId":"2570751","version":"1","preferredName":"Total Bilirubin","longName":"2570751","preferredDefinition":"Total Bilirubin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E16C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CFB9-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"Alkaline Phosphatase","valueDescription":"Alkaline Phosphatase","ValueMeaning":{"publicId":"2570082","version":"1","preferredName":"Alkaline Phosphatase","longName":"2570082","preferredDefinition":"Alkaline Phosphatase","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DECF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CFC4-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"},{"value":"AST","valueDescription":"AST","ValueMeaning":{"publicId":"3109753","version":"1","preferredName":"AST","longName":"3109753","preferredDefinition":"AST","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CFCF-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8903BFCE-CFE8-331C-E040-BB89AD431B7C","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ONEDATA","dateModified":"2010-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CF07-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ALAIS","dateModified":"2010-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which of the following tests","type":"Preferred Question Text","description":"Which of the following tests were performed?","url":null,"context":"CTEP"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8903BFCE-CFF2-331C-E040-BB89AD431B7C","latestVersionIndicator":"Yes","beginDate":"2010-06-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-14","modifiedBy":"ALAIS","dateModified":"2010-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}